Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.
Idorsia receives approval from Health Canada for JERAYGO (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.JERAYGO is a new oral ant ...
Idorsia receives approval from Health Canada for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist ...
FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo Nordisk.
Everyday Health on MSN
There’s a New Drug for Motion Sickness — the First in 40 Years
The FDA approved the pill Nereus (tradipitant) as a new treatment for vomiting caused by motion sickness, with fewer side ...
There's now a prescription GLP-1 pill for weight loss on the market. Here are six key things to know about it.
You are sensitive, perceptive and attuned to the finer details of your surroundings. You are motivated, diligent and hardworking. Simplicity is the ...
Credit Human Share Certificates made our list of the best five-year CD accounts thanks to its competitive APY and relatively low minimum deposit requirement. We like that Credit Human Share ...
The MGS5 EV takes the brand’s electric SUV range to new heights thanks to its combination of space, standard equipment and range. It also feels appropriately tuned for UK roads and is surprisingly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback